Home
About
Technology
Pipeline
Investors
News
Contact

PAT-DX1 in Combination with Radiation Therapy Significantly Improves Survival in Animal Model of Brain Cancer

Patrys Limited

Patrys is a publicly-listed company company focused on developing novel antibody technologies for hard-to-treat cancers.

Newsletter

Get news and updates from Patrys delivered to your inbox.

Stay Connected

Keep up to date with the latest news from Patrys by following us on social media.

© 2021 Patrys Limited. All rights reserved.

ASX
Privacy Policy

Menu